Using eosinophil response to predict cardiovascular outcomes in patients with ST- elevation myocardial infarction who

Joyce Lim1,2, Trent Williams1,2,3, Lucy Murtha2,3

  • 1Heart and Stroke Research Program, Hunter Medical Research Institute, New Lambton Heights, NSW, Australia.

Insights

Eosinophil response after ST-elevation myocardial infarction (STEMI) predicts short-term major adverse cardiovascular events (MACE). A decrease in eosinophils greater than -0.05 × 10^9/L is highly sensitive for predicting 30-day MACE.

Area of Science:

  • Cardiology
  • Immunology
  • Biomarker Discovery

Background:

  • Eosinophils are involved in inflammation post-STEMI.
  • The predictive value of eosinophils for MACE is not well-established.

Purpose of the Study:

  • To assess the predictive capability of eosinophil response for 30-day and 1-year MACE after primary PCI in STEMI patients.

Main Methods:

  • Retrospective cohort study of 366 STEMI patients undergoing PCI.
  • Eosinophil response defined as change in cell count from admission to 48h post-PCI.
  • ROC curves and multivariate logistic regression used to analyze MACE prediction.

Main Results:

  • An eosinophil response > -0.05 × 10^9/L predicted 30-day MACE with 83% sensitivity and 98% negative predictive value.
  • This eosinophil change was associated with a threefold increased likelihood of 30-day MACE (OR 3.1).
  • No significant prediction for 1-year MACE was observed.

Conclusions:

  • Eosinophil response at 48h post-PCI is a sensitive predictor of 30-day MACE in STEMI patients.
  • Absence of a significant eosinophil decrease has a high negative predictive value for 30-day MACE.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
273
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
71